Avoid These 10 Mistakes When Prescribing SGLT2 Inhibitor and GLP-1s Thierry Hannedouche, MD, PhD logo Medscape Europe May 11, 2026

https://www.medscape.com/viewarticle/avoid-these-10-mistakes-when-prescribing-sglt2-inhibitor-and-2026a1000ezt?ecd=wnl_edit_tpal_etid8335039&uac=148436CN&impID=8335039 SGLT2 inhibitors and GLP-1 receptor agonists (RAs), have transformed the management of type 2 diabetes (T2D), obesity, chronic kidney disease (CKD), and heart failure (HF). Their benefits extend well beyond glycemic control and weight loss and include cardiorenal (CR) protection. However, integration into primary care practice can lead to predictable errors that limit therapeutic benefits or expose patients to avoidable risks. This article outlines 10 common mistakes and proposes practical strategies to optimize their use in daily practice.